Cat. No. 1476
Biological ActivityPeptide derived from connexin 43 that is a selective gap junction blocker. Attenuates ACh-induced arterial relaxation and reduces K+-mediated smooth muscle repolarization in endothelium-intact vessels in vitro.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Richards et al (2001) Suppression of K+-induced hyperpolarization by phenylephrine in rat mesenteric artery: relevance to studies of endothelium-derived hyperpolarizing factor. Br.J.Pharmacol. 134 1. PMID: 11522590.
Ko et al (2000) Biochemical and functional characterization of intercellular adhesion and gap junctions in fibroblasts. Am.J.Physiol.Cell Physiol. 279 C147. PMID: 10898726.
Chaytor et al (1998) Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J.Physiol. 508 561. PMID: 9508817.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Gap 27 include:
Westphalen et al (2014) Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature 506 503. PMID: 24463523.
Do you know of a great paper that uses Gap 27 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Gap 27, supplier, Selective, gap, junction, blockers, Connexins, Gap, Channels, modulators, Gap27, Tocris Bioscience, Gap Channel Blocker products
Find multiple products by catalog number
New Products in this Area
Activator of STING-dependent signaling3',3'-cGAMP sodium salt
STING agonist2',3'-cGAMP sodium salt
Endogenous high affinity STING agonistc-Di-AMP sodium salt
Endogenous STING and DDX41 agonist; activates STING-dependent signalingc-Di-GMP sodium salt
Endogenous STING and DDX41 agonist; activates STING-dependent signalingCPYPP
DOCK2-Rac1 interaction inhibitor
November 12 - 16, 2016
San Diego, CA, USA